Professor Dr. Xavier Obradors, EUROTAPES project coordinator and Director of ICMAB, added: “The project is an excellent opportunity to advance a very fruitful cooperation between European partners from academia and industry in the field of the development of advanced nanostructured second generation coated conductors. Certainly the know-how complementarities and the achieved critical mass will contribute to push European industry towards an international leadership position in high-tech sectors related to electrical power infrastructures and medical or biomedical equipment.”
For more information on the EUROTAPES program, please visit:
About Bruker Energy & Supercon Technologies, Inc. (BEST)
BEST is a subsidiary of Bruker Corporation (NASDAQ: BRKR), and is a leader in the development and industrial manufacturing of advanced superconducting materials and superconducting devices for alternative energy, smart grid, healthcare and ‘big science’ applications. For more information on BEST, please visit
CAUTIONARY STATEMENT OF BEST
This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. In many cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential," "continue" or other similar words.
These forward-looking statements are predictions, not guarantees. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, levels of activity, performance or achievements to materially differ from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those projected, include, but are not limited to, the integration of businesses we have acquired or may acquire in the future, changing technologies, product development, the cost and pricing of our products, manufacturing, competition, dependence on collaborative partners and key suppliers, capital spending and government funding policies, changes in governmental regulations, intellectual property rights, litigation, and exposure to foreign currency fluctuations. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as guarantees of future events.